Credit Suisse’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Hold
0
4019
2022
Q2
Hold
0
3907
2021
Q1
Sell
-4
Closed -$26K 3406
2020
Q4
$26K Buy
+4
New +$26K ﹤0.01% 3433